What is the bull case for Aehr Test Systems (AEHR)?

2026-07-14: FY2027 revenue guided $130.0M–$150.0M versus $85.132M consensus. A guide that far above the Street is the single hardest datapoint in this file; it forces model revisions across every analyst covering the name rather than a debate about order timing. 2026-07-14: Q4 FY26 adjusted EPS $0.11 versus $(0.01) estimate, revenue $18.835M versus $18.686M. The Q4 return-to-profitability guide from the Q3 call was met, confirming the operating-leverage inflection is real at…

What is the bear case for Aehr Test Systems (AEHR)?

The stock is up roughly 410% over twelve months and has now gapped ~29% on the print. Buying the first green candle after a guidance blowout on a $2.1B micro-cap means buying from every holder who waited for exactly this event to sell. Concentration risk did not disappear. The bulk of H2 FY26 bookings still traces to one lead ASIC customer. A single push-out or a design-win loss at that account takes a double-digit percentage out of the FY27 guide, and there is no second…

Dossier · AEHR · Watchlist

AEHR · Aehr Test Systems · Stock research

Q: Is AEHR a buy?

orbyd does not issue buy or sell ratings — it publishes a dated, falsifiable thesis and the exact trigger that would prove it wrong. Q4 FY26 (2026-07-14) beat at $0.11 adj EPS vs $(0.01) est, but the re-rating driver is the FY27 revenue guide of $130-150M vs $85.1M consensus a 53-76% blowout that compresses ~65x trailing sales to ~15x forward. Stock gapped +29% to ~$93; the binary that capped it all spring has cleared, plus $8M of new SiC orders and a second photonics follow-on.

HIGH Cyclical recovery Catalyst · 2026-07-21 semi-foundry-equipment ai-chips-memory networking-optical

Last analysed · 2026-07-19T08:11:52+00:00

Current thesis

Q4 FY26 (2026-07-14) beat at $0.11 adj EPS vs $(0.01) est, but the re-rating driver is the FY27 revenue guide of $130-150M vs $85.1M consensus a 53-76% blowout that compresses ~65x trailing sales to ~15x forward. Stock gapped +29% to ~$93; the binary that capped it all spring has cleared, plus $8M of new SiC orders and a second photonics follow-on.

Invalidation trigger

A weekly close below $80 says the guidance gap is being distributed and puts price back inside the pre-print base; secondarily, any push-out or reduction of FY2027 deliveries from the lead hyperscale customer, or a walk-back off the $130-150M guide at the Q1 FY27 print (~2026-10, est.).

Thesis status

Open commitment catalyst in 2dscored if the trigger above fires How this is scored →

Latest analysis and events for AEHR — 2026-07-14

As of 2026-07-14, orbyd's latest analysis for Aehr Test Systems (AEHR): >$8M new silicon-carbide wafer-level burn-in orders the SiC leg is re-firing after the EV-inventory correction. Third demand vector alongside AI-ASIC PLBI and silicon photonics.

Invalidation trigger: A weekly close below $80 says the guidance gap is being distributed and puts price back inside the pre-print base; secondarily, any push-out or reduction of FY2027 deliveries from the lead hyperscale customer, or a walk-back off the $130-150M guide at the Q1 FY27 print (~2026-10, est.).

Next dated event on file: 2026-07-21 — catalyst in 2d.

Current Thesis

The binary that capped this name all spring has resolved, and it resolved to the upside. Q4 FY26 (reported 2026-07-14, after the close) printed adjusted EPS of $0.11 against a consensus loss of $(0.01), on revenue of $18.835M versus $18.686M expected but the number that re-rated the stock was the FY2027 revenue guide of $130.0M–$150.0M against a Street estimate of $85.132M. That is a guide roughly 53–76% above where sell-side models sat, and it converts the burn-in story from a hopeful order-flow narrative into a booked, dated revenue ramp. The critical mechanical consequence: at the midpoint of the FY27 guide ($140M), the multiple compresses from roughly 65x trailing sales to about 15x forward the valuation objection that justified standing aside in June was retired by the company's own guidance, not by a drawdown. On top of the print, more than $8M of new silicon-carbide wafer-level burn-in orders landed 2026-07-14, and the CEO stated on 2026-07-15 that AI will be a larger piece of the business as orders keep rolling in. The demand base is now three-legged AI-ASIC package-level burn-in, silicon photonics, and a re-firing SiC line where in April it was effectively one hyperscale customer.

Bullish and bearish views on Aehr Test Systems

The model's bull view on Aehr Test Systems (AEHR), in brief: 2026-07-14: FY2027 revenue guided $130.0M–$150.0M versus $85.132M consensus. The bear view: The stock is up roughly 410% over twelve months and has now gapped ~29% on the print. Both cases follow in full.

Bull Case

2026-07-14: FY2027 revenue guided $130.0M–$150.0M versus $85.132M consensus. A guide that far above the Street is the single hardest datapoint in this file; it forces model revisions across every analyst covering the name rather than a debate about order timing.
2026-07-14: Q4 FY26 adjusted EPS $0.11 versus $(0.01) estimate, revenue $18.835M versus $18.686M. The Q4 return-to-profitability guide from the Q3 call was met, confirming the operating-leverage inflection is real at this revenue scale.
2026-07-14: more than $8M in new silicon-carbide wafer-level burn-in orders announced alongside the print. SiC was the legacy vector the market had written off during the EV-inventory correction; its return adds a third demand leg independent of AI.
2026-07-09: additional follow-on production order from the lead silicon-photonics customer for a fully automated FOX-XP wafer-level burn-in system, +13.6% on the session, 12-month return 410.84%. A repeat order within three weeks of the 2026-06-17 first order (+11%) makes photonics a program rather than a pilot.
2026-04-16: record $41M follow-on production order largest in company history from the lead hyperscale AI customer for package-level burn-in of custom AI ASICs, Sonoma systems plus turnkey modules and sockets, for FY2027 delivery. This is the revenue that underwrites the FY27 guide.
Q3 FY26 call: H2 FY26 bookings above $92M against a raised $60–80M guide, book-to-bill near 3.6x. The backlog was visible before the print; the guide simply put a delivery schedule on it.
Cluster confirmation on 2026-07-09: the move ran alongside LRCX, KLAC, ONTO, FORM, ICHR, LITE and ARM. Semicap and AI-test are accelerating as a complex.

Bear Case

The stock is up roughly 410% over twelve months and has now gapped ~29% on the print. Buying the first green candle after a guidance blowout on a $2.1B micro-cap means buying from every holder who waited for exactly this event to sell.
Concentration risk did not disappear. The bulk of H2 FY26 bookings still traces to one lead ASIC customer. A single push-out or a design-win loss at that account takes a double-digit percentage out of the FY27 guide, and there is no second $20M+ hyperscaler order publicly confirmed.
Insider selling printed into the spring run via Form 4 ownership reductions. Management was a seller at the highs; watch whether the post-print window produces more.
Float is roughly 30M shares with 12–21% single-session ranges routine. The June cooldown produced -15% (to $84.62) and -12.5% (to $87.05) sessions inside an uptrend. Loose stops get wicked out on noise.
Guidance of $130–150M implies roughly 2.2–2.5x revenue growth in a single fiscal year for a company that shipped ~$59M trailing. Execution risk capacity, supply of sockets and modules, installation schedules is now the whole story, and the first quarterly checkpoint is roughly ten weeks out.
A $60M ATM shelf filed 2026-04-08 with William Blair and Craig-Hallum as agents remains open. At $90+ the per-dollar dilution is modest, but a post-print raise into strength is exactly how a company funds a 2.5x capacity ramp.

Setup & Price Structure

The structure changed shape on 2026-07-14. Prior to the print the stock had faded from the 2026-06-02 all-time high of $113.20 through an $80–90 shelf and down toward the low $70s, building what looked like a lower-high failure into the binary. The earnings gap from roughly $72 to $91.50–$93.30 erased that read in one session: the move recovered the entire $80–90 shelf from below and re-established price inside the June distribution range on the largest fundamental datapoint in the company's history. That is a gap-and-go off a resolved binary, and the unfilled gap between roughly $75 and $88 is the structural feature that matters gaps created by guidance revisions of this magnitude tend not to fill, because the buyer base changed.

The reference levels: $113.20 is the 2026-06-02 all-time high and the obvious magnet if the semicap complex keeps accelerating. The $80–90 band is now support-from-resistance and the first place to judge whether the gap holds. Below that, roughly $72 was the pre-print base. RSI will be extended after a 29% session; on this playbook that is confirmation of the guidance repricing rather than a reason to wait, and the fresh-catalyst clock has just been reset there is no earnings blackout and no binary event inside the next ten weeks. What tempers sizing is not the chart but the concentration: one customer still drives the guide, and a $2.1B micro-cap with a 30M float re-prices violently in both directions.

Catalyst Calendar (next 30 days)

2026-07-15 through ~2026-07-31: post-print analyst revision window. William Blair and Craig-Hallum are the house brokers; price-target and estimate revisions off a $130–150M FY27 guide versus $85M prior models are the mechanical follow-through to watch. Clustered upgrades inside 14 days would confirm the narrative is being institutionalized.
Ongoing, no fixed date: the unfired binary a production order of $20M or more from a SECOND, distinct hyperscale AI customer. This remains the upgrade trigger that would take the story from one-account leverage to a platform.
~2026-09-25 to ~2026-10-08 (est.): Q1 FY2027 results, the first checkpoint against the new guide. Outside the 30-day window but the date that governs how much rope the ramp gets.
10-K for FY2026 expected filed within roughly 60–90 days of the 2026-06 fiscal year-end; customer-concentration disclosure in that filing is the cleanest public read on how much of revenue the lead account represents.

Elapsed catalysts

Ongoing, no fixed date: additional silicon-photonics FOX-XP production orders. Two landed within three weeks (2026-06-17, 2026-07-09); a third would establish a cadence and further de-risk single-customer dependence. _(passed 10d ago)_

What Would Change Our Mind

A weekly close below $80 would say the guidance gap is being sold rather than bought, putting price back inside the pre-print base and turning the 29% move into a liquidity event for exit-minded holders. That is the level where the structural read breaks.

Beyond price: any disclosure that the lead hyperscale customer has pushed out or reduced FY2027 deliveries most likely surfacing on the Q1 FY27 call would gut the $130–150M guide, since that account underwrites the bulk of it. A guidance cut or a walk-back to the low end at the first checkpoint carries the same weight. Continued Form 4 selling by officers into post-print strength, or an equity raise off the open $60M ATM priced at a discount to the gap, would both argue the insiders think this is the price. And if the photonics orders stop no third FOX-XP order over the next quarter the diversification leg that made this more than a single-program story goes quiet.

Correlation Notes

Semicap and AI-test complex: LRCX, KLAC, ONTO, FORM, ICHR moved together on 2026-07-09. AEHR is the highest-beta expression in that basket by an order of magnitude; the group trend is the regime filter, and a rollover in LRCX/KLAC would remove the tailwind regardless of company-specific orders.
Silicon photonics / co-packaged optics: LITE, and by extension the CPO buildout at the hyperscalers, is the demand source for the FOX-XP photonics orders. Weakness there front-runs the second demand leg.
Custom AI ASIC: ARM, and the merchant-versus-custom-silicon debate generally. AEHR's largest customer is a hyperscaler building custom accelerators; any evidence that custom-silicon programs are being deprioritized in favor of merchant GPUs is a direct threat.
Silicon carbide: the SiC leg correlates with power-semiconductor and EV capex, a different and slower cycle than AI. The $8M order set on 2026-07-14 suggests that cycle is bottoming, which would make the three demand legs genuinely uncorrelated the structural argument for a higher multiple over time.
Position sizing caveat that overrides all of the above: a 30M float with 12–21% daily ranges means the name's realized volatility, not its correlation profile, is the binding constraint on exposure.

Notes

2026-04-18: seed: Serenity/attention list
Q4/FY26 earnings blackout starts ~mid-June 2026; next print ~mid-July 2026.
Float ~30M
10–30% news-driven moves are normal size small on probes.
ATM overhang: every rally meets paper from William Blair / Craig-Hallum agents until $60M is worked.
Second hyperscaler order ≥$20M is the binary long trigger not the first order.
Archetype upgraded 7→2: pivot is no longer emergent it's a proven picks-and-shovels AI-ASIC burn-in supplier (repeat $41M follow-on order, $92M H2 bookings, FY27 deliveries, Q4 non-GAAP profit guide).
Prior two avoids (2026-05-15, 2026-05-26) were the documented alpha leak name ran ~$40 to $113 while we waited. Lesson: on ACCELERATING+cluster-confirmed, the clean breakout entry was the trade, not the 'wait for 2nd order' defer.
CRITICAL nuance: the $41M is a follow-on from the SAME lead hyperscale customer (2026-02 initial Sonoma order). A SECOND DISTINCT hyperscaler order (≥$20M) is still the unfired diversification binary that's the HIGH-conviction upgrade trigger.
Q4/FY26 earnings ~2026-07-07 (Benzinga) or 2026-07-21 (TipRanks); est EPS -$0.02 on ~$18.69M rev. Blackout starts ~mid-June 2026. FY2027 begins ~2026-06-27.
Float ~30M, high-beta; 12-21% single-session candles are normal. Current tape is mania/parabolic.
$60M ATM (filed 2026-04-08, William Blair / Craig-Hallum) is now largely defused at $113 vs ~$30-40 filing price the per-dollar dilution is small. Overhang is no longer the dominant cap; valuation/sentiment is.
Saturation tells active: mainstream 'how much you'd have made' + '5 small caps up 400%' coverage (2026-05-12, 2026-06-02/03) + insider selling = late-stage for THIS expression even though the ai-chip theme is still ACCELERATING.
Q4/FY26 earnings ~2026-07-07 (Benzinga) or ~2026-07-21 (TipRanks); est EPS -$0.02 on ~$18.69M rev. Blackout starts ~mid-June 2026. FY2027 begins ~2026-06-27.
Next print is OUTSIDE the 30-day window as of 2026-06-04 → catalyst_date null; the interim tape is pure flow/sentiment, worst condition to chase a parabola.
SECOND DISTINCT hyperscaler order >=$20M is the unfired HIGH-conviction binary. The $41M (2026-04-16) is a follow-on from the SAME lead customer as the 2026-02 initial Sonoma order repeat-buyer is bullish but concentration risk remains.
Prior two avoids (2026-05-15, 2026-05-26) were the documented alpha leak name ran ~$40 to $113 while we waited. Lesson: on ACCELERATING+cluster-confirmed, the clean breakout retest is the trade; the parabola's exhaustion candle ($113 on 06-02) is NOT.
Archetype is a2 (proven picks-and-shovels AI-ASIC burn-in: repeat $41M order, $92M H2 bookings, Q4 non-GAAP profit guide) but the CURRENT tape is mania/parabolic LOW conviction is the governor, not the archetype cap.
Float ~30M, high-beta; 12-21% single-session candles are normal. Recent intramove flushes -15% (to $84.62) and -12.5% (to $87.05) before rebounds.
$60M ATM (filed 2026-04-08, William Blair / Craig-Hallum) is largely defused at $113 vs ~$30-40 filing price minimal dilution per dollar. Overhang is no longer the dominant cap; valuation/sentiment is (P/S ~65, P/B ~21).
Saturation tells active: mainstream 'how-much-you'd-have-made' (2026-05-12) + 'Russell 2000 winners up 400%+' coverage (2026-06-02/03) + insider selling (Form 4) = late-stage for THIS expression even though the ai-chip theme is still ACCELERATING.
Key levels: ATH $113.20 (2026-06-02). Invalidation/parabola-break = daily close <$84. Cluster: AAOI/AXTI/AOSL/EUV photonics ETF basket strength confirms, basket rollover is the exit signal.
2026-04-18 seed: Serenity/attention list.
Q4/FY26 earnings ~2026-07-07 (Benzinga) or ~2026-07-21 (TipRanks); est EPS -$0.02 on ~$18.69M rev. Earnings blackout begins ~mid-June 2026. FY2027 begins ~2026-06-27 (the $41M Sonoma order is FY27-delivery backlog).
Second DISTINCT hyperscaler PLBI order ≥$20M is the unfired HIGH-conviction trigger. The 2026-04-16 $41M is a follow-on from the SAME lead customer (2026-02 initial Sonoma order), not a diversification of the demand base.
Float ~30M, high-beta; 12-21% single-session candles are normal (recent -15% to $84.62, -12.5% to $87.05). Run tight, retail-squeeze-grade sizing and never average down despite the a2 picks-and-shovels fundamental classification current tape is parabolic/mania.
$60M ATM (filed 2026-04-08, William Blair/Craig-Hallum) largely defused at $113 vs ~$30-40 filing-era price; valuation/sentiment is now the dominant cap on rallies, not the ATM.
Saturation active: mainstream 'how-much-you'd-have-made' retrospective (2026-05-12) + 'small caps up 400%' coverage (2026-06-02/03) + insider Form 4 selling = late-stage for THIS expression even as the ai-chip theme stays ACCELERATING.
Discipline: on ACCELERATING + cluster-confirmed names the clean breakout retest is the entry; chasing a parabola's exhaustion candle at the highs is the trap. Reset point is a higher-low hold of the $80-90 shelf.
Theme registry auto-tagged 'semiconductor-analog-components' on 2026-06-05 inaccurate; AEHR is semiconductor test/burn-in for AI ASICs, retagged accordingly.
Q4/FY26 earnings ~2026-07-07 (Benzinga) or ~2026-07-21 (TipRanks); est EPS -$0.02 on ~$18.69M rev. Blackout in effect since ~mid-June 2026; FY27 begins ~2026-06-27.
2026-06-17: follow-on FOX-XP wafer-level burn-in order for SILICON PHOTONICS (+11%) a second product vector beyond AI-ASIC PLBI; broadens the story but is NOT the second-distinct-hyperscaler-ASIC binary.
HIGH-conviction upgrade trigger remains an 8-K with a SECOND DISTINCT hyperscaler ASIC order >=$20M. The $41M Apr-16 order was a follow-on from the SAME lead customer (2026-02 initial Sonoma order).
Float ~30M, high-beta; 11-21% single-session candles are normal. Current tape is mania/parabolic.
$60M ATM (filed 2026-04-08, William Blair / Craig-Hallum) largely defused at current price vs ~$30-40 filing era; valuation/sentiment, not dilution, is now the dominant cap.
Saturation tells active: mainstream 'how much you'd have made' (2026-05-12) + '5 small caps up 400%' (2026-06-02/03) + insider selling = late-stage for THIS expression even though the ai-chip theme is still ACCELERATING.
Key levels: $80-90 breakout shelf = line in the sand; $113.20 ATH (2026-06-02) = overhead supply needing a fresh distinct-customer catalyst to clear.
Prior-cycle lesson: avoiding the clean ACCELERATING+cluster-confirmed breakout while waiting for the 2nd order was a documented alpha leak (~$40 to $113). The breakout was the trade, not the wait.
Q4/FY26 earnings ~2026-07-21 (TipRanks est.); est EPS -$0.02 on ~$18.69M rev; blackout in effect through the print no new order press until after.
Photonics vector now shows REPEAT orders: 2026-06-17 first FOX-XP photonics order (+11%) then 2026-07-09 additional follow-on from same lead photonics customer (+13.6%). Program, not one-off.
The unfired binary is a SECOND DISTINCT hyperscaler ASIC order (≥$20M from a NEW buyer). All follow-ons to date ($41M 2026-04-16, photonics 06-17/07-09) are repeats from existing accounts.
Float ~30M, high-beta; 12-21% single-session candles routine (-15%/-12.5% air-pockets in June). Size small, never average down despite picks-and-shovels fundamentals tape is mania-grade.
$80-90 shelf is the operative base; held through June cooldown after $113.20 ATH (2026-06-02). Weekly close <$80 = structure break.
Saturation tells active: mainstream 'how much $100 would be worth' retrospectives + AEHG 2X leveraged ETF launch (2026-06-26) = late-stage for THIS expression even as the AI-test theme stays ACCELERATING.
$60M ATM (William Blair / Craig-Hallum, filed 2026-04-08) largely defused at current prices vs ~$30-40 filing era valuation/sentiment now the dominant cap, not dilution.
Prior avoids while the name ran ~$40→$113 were the documented alpha leak; the clean breakout retest of the $80-90 shelf is the entry to catch, not another blowoff chase.
2026-07-14 Q4/FY26 PRINT CLEARED: adj EPS $0.11 vs $(0.01) est, rev $18.835M vs $18.686M est. FY27 guide $130-150M vs $85.132M consensus. Stock +27.1% AH to ~$91.50, +29.6% pre-market to $93.30. Market cap ~$2.1B.
The binary blocker that justified standing aside from May through mid-July is RESOLVED to the upside. Valuation objection retired by guidance, not by drawdown: ~65x trailing sales becomes ~15x forward at the $140M guide midpoint.
Earnings gap runs roughly $72 -> $91.50/$93.30, leaving an unfilled gap between ~$75 and ~$88. A gap created by a guidance revision of this magnitude is structurally different from a sentiment gap.
Next earnings checkpoint ~2026-09-25 to ~2026-10-08 (est., Q1 FY27). No blackout and no binary event inside the next ten weeks the cleanest catalyst-free window this name has had since February.
2026-07-14: >$8M new silicon-carbide wafer-level burn-in orders the SiC leg is re-firing after the EV-inventory correction. Third demand vector alongside AI-ASIC PLBI and silicon photonics.
STILL UNFIRED: a SECOND distinct hyperscaler order of >=$20M. Bulk of H2 FY26 $92M bookings still traces to the one lead ASIC customer. That order is the upgrade-to-platform trigger.
Photonics cadence: first FOX-XP production order 2026-06-17 (+11%), follow-on from the SAME customer 2026-07-09 (+13.6%). A third order would establish a program cadence; silence for a quarter is a warning.
Float ~30M shares, 12-21% single-session ranges are routine. Realized volatility, not correlation, is the binding sizing constraint. Never average down on this name.
$60M ATM (filed 2026-04-08, William Blair / Craig-Hallum agents) remains open. A discounted raise into post-print strength would be a negative signal about how insiders view the price.
Insider selling via Form 4 ownership reductions printed into the spring run. Watch the post-print window for more.
All-time high $113.20 set 2026-06-02 (William Blair conference day, +15.1%). $80-90 is the shelf that now flips from resistance to support.
2026-06-26: Leverage Shares launched AEHG, a 2X leveraged ETF on the name structural attention/flow signal.
Documented alpha leak on this ticker: standing aside twice in spring 2026 (2026-05-15, 2026-05-26) while the name ran ~$40 to $113. On ACCELERATING + cluster-confirmed semicap, waiting for confirmation that already exists is the error mode.

Related · shared themes

SIMO

Silicon Motion Technology Corporation

NAND-controller toll-booth on the steepest flash shortage in ~15 years: TrendForce H1 2026 contract +>100% cumulative, H2 still rising with no capacity adds. Q1 record +105% YoY, sell-side chasing to $400/$450. Fundamental leg ACCELERATING, but the tape is digesting a 4x into insider selling the 2026-07-29 Q2 print is the next binary.

MEDIUM

AMD

Advanced Micro Devices, Inc.

MI450/Helios rack-scale plus EPYC agentic-CPU narrative drove ATHs near $561.80 (7/1), but the July target cluster ($600 BNP, $620 BofA, $725 high) is arriving into a falling tape 20-day MA lost 7/8, chip-led Nasdaq selloff 7/17, sentiment into Fear. Sell-side catch-up after the move, with the 8/4 print as the binary.

LOW

HPE

Hewlett Packard Enterprise Company

AI-server and enterprise-networking pivot is real at the theme level, but HPE's own chart broke: the record +25% Q2 FY26 blowoff (2026-06-02, ATH $64.25) fully round-tripped, the ~$48 pre-print shelf failed (last observed close $43.71 on 6/26), and nothing is dated until the Q3 print in early September. A fresh buy here catches the breakdown, not a base.

LOW

IRDM

Iridium Communications Inc

Narrative-momentum thesis is closed: Rocket Lab agreed 2026-06-29 to acquire Iridium for ~$54/share ($27 cash + a calculated ratio of RKLB stock), EV ~$8B. IRDM now trades as merger-arb spread to ~$54 plus embedded RKLB beta not on NTN Direct or spectrum. Morgan Stanley's PT-to-$54 (2026-06-30) confirms the Street marks it to the deal. Upside is capped at terms; the live binary is deal close vs. break on a 6–12 month regulatory clock.

LOW